This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n8	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n12	http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000134/
n3	http://linked.opendata.cz/ontology/sukl/
n17	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149503/price-of-originator/
skos	http://www.w3.org/2004/02/skos/core#
n10	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149503/reimbursement/
n16	http://linked.opendata.cz/resource/sukl/indgroup/
n7	http://linked.opendata.cz/resource/sukl/packing/
n13	http://linked.opendata.cz/resource/sukl/company/
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149503/
n18	http://linked.opendata.cz/resource/sukl/active-ingredient/
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149503/core-reimbursement/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149503/price/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n6	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n19	http://linked.opendata.cz/resource/atc/
n14	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0149503

rdf:type

n3:MedicinalProductPackaging

dcterms:title

MIRAPEXIN 0,26 MG

skos:notation

0149503

n3:hasATCCode

n19:N04BC05

n3:hasActiveIngredient

n18:PRAMIPEXOLI-DIHYDROCHLORIDUM-MONOHYDRICUM

n3:hasDefinedDailyDose

n15:ddd

n3:hasDosageForm

n14:TBL-PRO-POR

n3:hasPackagingSize

10

n3:hasPacking

n7:BLI

n3:hasRegistrationHolder

n13:BOED

n3:hasRegistrationState

n6:R

n3:hasRouteOfAdministration

n8:POR

n3:hasStrength

0.26MG

n3:hasIndicationGroup

n16:27

n3:hasSpecializationRestriction

n17:NEU

n3:containsDefinedDailyDoses

1.5

n3:hasRegistrationCode

EU/1/97/051/013

n3:hasTitleSupplement

POR TBL PRO 10X0.26MG

n3:containsUsualTherapeuticalDailyDoses

1.2381

n3:hasCoreReimbursementSpecification

n9:2015-04-02 n9:2015-05-01 n9:2015-03-01 n9:2015-04-01 n9:2015-01-13 n9:2015-02-01 n9:2014-12-01 n9:2015-01-01 n9:2014-11-01 n9:2014-11-19 n9:2014-10-01 n9:2014-10-02 n9:2014-08-01 n9:2014-09-01 n9:2014-07-01 n9:2014-07-03 n9:2015-07-02 n9:2015-06-01 n9:2015-07-01 n9:2013-03-01 n9:2013-04-01 n9:2013-01-05 n9:2013-02-01 n9:2013-01-01 n9:2014-06-01 n9:2014-06-13 n9:2014-04-01 n9:2014-05-01 n9:2014-02-01 n9:2014-03-01 n9:2013-12-01 n9:2014-01-01 n9:2013-10-01 n9:2013-11-01 n9:2013-08-03 n9:2013-09-01 n9:2013-07-01 n9:2013-08-01 n9:2013-05-01 n9:2013-06-01

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n4:2015-01-13 n4:2015-02-01 n4:2014-12-01 n4:2015-01-01 n4:2015-04-02 n4:2015-05-01 n4:2015-03-01 n4:2015-04-01 n4:2015-07-02 n4:2015-06-01 n4:2015-07-01 n4:2014-02-01 n4:2014-03-01 n4:2013-12-01 n4:2014-01-01 n4:2014-06-01 n4:2014-06-13 n4:2014-04-01 n4:2014-05-01 n4:2014-08-01 n4:2014-09-01 n4:2014-07-01 n4:2014-07-03 n4:2014-11-01 n4:2014-11-19 n4:2014-10-01 n4:2014-10-02 n4:2013-01-01 n4:2013-03-01 n4:2013-04-01 n4:2013-01-05 n4:2013-02-01 n4:2013-07-01 n4:2013-08-01 n4:2013-05-01 n4:2013-06-01 n4:2013-10-01 n4:2013-11-01 n4:2013-08-03 n4:2013-09-01

n3:hasPriceSpecification

n5:2013-01-05 n5:2013-02-01 n5:2013-03-01 n5:2013-04-01 n5:2013-01-01 n5:2014-10-01 n5:2014-10-02 n5:2014-11-01 n5:2014-11-19 n5:2014-07-01 n5:2014-07-03 n5:2014-08-01 n5:2014-09-01 n5:2015-03-01 n5:2015-04-01 n5:2015-04-02 n5:2015-05-01 n5:2014-12-01 n5:2015-01-01 n5:2015-01-13 n5:2015-02-01 n5:2013-08-03 n5:2013-09-01 n5:2013-10-01 n5:2013-11-01 n5:2013-05-01 n5:2013-06-01 n5:2013-07-01 n5:2013-08-01 n5:2014-04-01 n5:2014-05-01 n5:2014-06-01 n5:2014-06-13 n5:2013-12-01 n5:2014-01-01 n5:2014-02-01 n5:2014-03-01 n5:2015-06-01 n5:2015-07-01 n5:2015-07-02

n3:hasReimbursementSpecification

n10:2014-06-01 n10:2014-06-13 n10:2014-04-01 n10:2014-05-01 n10:2014-02-01 n10:2014-03-01 n10:2013-12-01 n10:2014-01-01 n10:2014-11-01 n10:2014-11-19 n10:2014-10-01 n10:2014-10-02 n10:2014-08-01 n10:2014-09-01 n10:2014-07-01 n10:2014-07-03 n10:2013-03-01 n10:2013-04-01 n10:2013-01-05 n10:2013-02-01 n10:2013-01-01 n10:2013-10-01 n10:2013-11-01 n10:2013-08-03 n10:2013-09-01 n10:2013-07-01 n10:2013-08-01 n10:2013-05-01 n10:2013-06-01 n10:2015-04-02 n10:2015-05-01 n10:2015-03-01 n10:2015-04-01 n10:2015-01-13 n10:2015-02-01 n10:2014-12-01 n10:2015-01-01 n10:2015-07-02 n10:2015-06-01 n10:2015-07-01

n3:hasResumedMarketingDate

2010-09-29+02:00

n3:hasUsualTherapeuticalDailyDose

n15:utdd

n3:spcFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000134%2FWC500029252.pdf

n3:spcUri

n12:WC500029252.pdf